STUDY OF EFFICACY AND SAFETY OF DIART® IN THE TREATMENT OF PATIENTS WITH KNEE OSTEOARTHRITIS OF THE II-III GRADE
Application in clinical practice of new class of drugs – symptom modifying slow-action drugs (SMOADs) – has significantly broadened treatment and rehabilitation measures in patients with knee osteoarthritis.